Medicine and Dentistry
Adenoma
7%
Age
6%
Analysis
9%
Antiviral Therapy
7%
Association
6%
Biological Marker
7%
Bleeding
8%
Body Mass Index
6%
Breathing
7%
Capsule Endoscopy
17%
Cells
6%
Child-Pugh Score
7%
Cholestasis
6%
Chronic Hepatitis B
22%
Chronic Hepatitis C
6%
Chronic Viral Hepatitis
6%
Cohort Analysis
9%
Colon
5%
Colonoscopy
11%
Colorectal Carcinoma
10%
Colorectal Tumor
6%
Combination Therapy
14%
Common Bile Duct Stone
6%
Crohn's Disease
6%
Decompensated Liver Cirrhosis
5%
Development
7%
Diagnosis
8%
Disease
8%
Disease Course
5%
Donor
7%
Endoscopic Mucosal Resection
6%
Endoscopic Retrograde Cholangiopancreatography
6%
Endoscopic Submucosal Dissection
8%
Endoscopic Surgery
8%
Endoscopic Ultrasound
5%
Endoscopy
14%
Esophagus
6%
Fibrosis
14%
Follow up
6%
Gastrectomy
7%
Gastroesophageal Reflux
10%
Gastrointestinal Disease
6%
Gene
6%
Hazard Ratio
9%
Helicobacter Pylori
10%
Hepatic Portal Vein
9%
Hepatitis B
14%
Hepatitis B Antigen
9%
Hepatitis B Virus
28%
Hepatitis B(e) Antigen
8%
Hepatitis C Virus
9%
Hepatocellular Carcinoma
100%
Hepatocyte
10%
In Vitro
6%
Inpatient
41%
Irritable Bowel Syndrome
9%
Lamivudine
6%
Liver
10%
Liver Cancer
14%
Liver Cirrhosis
22%
Liver Fibrosis
9%
Liver Function
6%
Liver Graft
14%
Liver Transplantation
33%
Living Donors
9%
Malignant Neoplasm
6%
Metastatic Carcinoma
11%
Mortality
5%
Neoplasm
43%
Nonalcoholic Fatty Liver
9%
Obstruction
9%
Odds Ratio
8%
Odds Ratio
6%
Overall Survival
16%
Patient
83%
Polyp
5%
Polypectomy
5%
Predictive Factor
8%
Prevalence
12%
Prognostic Factor
10%
Proton-Pump Inhibitor
7%
Randomized Controlled Trial
5%
Recurrent Disease
13%
Reflux
7%
Reflux Esophagitis
7%
Serum
6%
Stent
6%
Stent Placement
7%
Stomach Cancer
9%
Stricture
5%
Surgery
9%
Survival
8%
Survival Rate
7%
Symptom
10%
Therapeutic Procedure
29%
Transcatheter Arterial Chemoembolization
15%
Transplantation
8%
Treatment Response
6%
Tumor Thrombus
7%
Vascular Tissue Neoplasm
7%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
5%
Chemotherapy
6%
Chronic Hepatitis B
25%
Chronic Hepatitis B
7%
Chronic Hepatitis C
9%
Cisplatin
8%
Cohort Study
6%
Combination Therapy
6%
Doxorubicin
7%
Entecavir
7%
Fibrosis
8%
Helicobacter Pylori
14%
Hepatitis B
9%
Hepatitis B Antigen
7%
Hepatitis B Virus
25%
Hepatitis B Virus
5%
Hepatitis B(e) Antigen
8%
Hepatitis C Virus
9%
Inflammation
5%
Lamivudine
7%
Liver Cancer
8%
Liver Cell Carcinoma
65%
Liver Cell Carcinoma
20%
Liver Cirrhosis
12%
Liver Cirrhosis
6%
Liver Fibrosis
6%
Neoplasm
15%
Nonalcoholic Fatty Liver
5%
Overall Survival
11%
Peginterferon
5%
Photodynamic Therapy
6%
Placebo
7%
Prevalence
5%
Recurrent Disease
7%
Reflux Esophagitis
5%
Ribavirin
5%
Sorafenib
8%
Stomach Cancer
5%
Vascular Tumor
5%
Virus DNA
6%
Biochemistry, Genetics and Molecular Biology
Genotyping
9%
Hepatitis B Virus
14%
Hepatitis C Virus
10%
Hepatitis C Virus
5%
Hepatocyte
10%
Microsatellite Instability
5%
Nested Gene
8%